KROS EBITDA Margin
Keros Therapeutics Inc · EBITDA Margin
KROS EBITDA Margin
Latest reported-562.79%period ending
KROS EBITDA Margin (-11.68% → -562.79%)
Annual ebitda margin
High-resolution chart · PNG
KROS ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 38.2716% | |
| -5,234.4789% | |
| -100,779.4702% | |
| 0% | |
| -280.3532% | |
| 0% | |
| -118.9% | |
| -11.68% |